TRAIL-R2 levels were also attenuated in BG7 tumours treated with combination BTZ+NK cells compared to vehicle control or BTZ alone (p < 0.05 and p < 0.01, respectively, Figure 6F,G). The gene discussed is TNFRSF10B; the disease is neoplasm.